提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
213
天
Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early‐Phase Design
作者Kevin Roberts; Jeffrey Palmer; Jessica Volpe; Wei Zhong; Avery McIntosh
作者单位1. Pfizer Inc. Cambridge Massachusetts USA; 2. Takeda Cambridge Massachusetts USA; 3. Pfizer Inc. Collegeville Pennsylvania USA
265
天
A Fast, Flexible Simulation Framework for Bayesian Adaptive Designs—The R Package BATSS
作者Dominique‐Laurent Couturier; Rainer Puhr; Stephane Heritier; Thomas Jaki; Elizabeth G. Ryan
作者单位1. MRC Biostatistics Unit University of Cambridge Cambridge UK; 2. School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia; 3. Faculty of Informatics and Data Science University of Regensburg Regensburg Germany
203
天
Sample Size Reduction by Applying ML Based Causal Inference Methods
作者Ahrim Youn; Gang Han; Emma Gerard; Neeraj Poonia; Sergio Olmos; Bingzhi Zhang; Meehyung Cho; Andres Houseman
作者单位1. Evidence Generation and Decision Science, Sanofi Morristown New Jersey USA; 2. Evidence Generation and Decision Science, Sanofi Gentilly France; 3. Evidence Generation and Decision Science, Sanofi Hyderabad India; 4. Evidence Generation and Decision Science, Sanofi Barcelona Spain; 5. Biostatistics and Modeling, Argenx Boston Massachusetts USA
427
天
The Impact of Model Misspecification on the Individual Causal Association in Surrogate Endpoint Evaluation
作者Gokce Deliorman; Florian Stijven; Wim Van der Elst; Maria del Carmen Pardo; Ariel Alonso
作者单位1. Department of Statistics and O.R Complutense University of Madrid Madrid Spain; 2. L‐BioStat, KU Leuven Leuven Belgium; 3. Janssen Pharmaceutica, Companies of Johnson & Johnson Beerse Belgium; 4. Interdisciplinary Mathematics Institute (IMI), Complutense University of Madrid Madrid Spain
200
天
A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials
作者Tomoyuki Kakizume; Kentaro Takeda; Masataka Taguri; Satoshi Morita
作者单位1. Japan Biostatistics & Data Management Department, Daiichi Sankyo Co. Ltd Tokyo Japan; 2. Quantitative Sciences and Evidence Generation, Astellas Pharma Global Development, Inc Northbrook Illinois USA; 3. Department or Health Science Tokyo Medical University Tokyo Japan; 4. Department of Biomedical Statistics and Bioinformatics Kyoto University Graduate School of Medicine Kyoto Japan
441
天
Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control
作者Quynh Nguyen; Martin Posch; Benjamin Hofner; Franz König
作者单位1. Section Data Science and Methods Paul‐Ehrlich‐Institut Langen Germany; 2. Department of Medical Informatics Biometry, and Epidemiology, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen Germany; 3. Institute of Medical Statistics, Center for Medical Data Science Medical University of Vienna Austria
204
天
Harmonic Fowlkes‐Mallows Index for Medical Diagnostics Tests and Optimal Cut‐Off Point Selection of Binary Diseases
作者Parthkumar Rabari; Purbasha Biswas; Jing X. Kersey; Hani Samawi
作者单位1. Department of Biostatistics, Epidemiology, and Environmental Health Sciences Jiann‐Ping Hsu College of Public Health, Georgia Southern University Statesboro Georgia USA
190
天
Early Phase Dose‐Finding Designs for CAR ‐T Cell Therapies
作者Weishi Chen; Pavel Mozgunov; Jimmy Mullaert; Xavier Paoletti
作者单位1. MRC Biostatistics Unit University of Cambridge Cambridge UK; 2. Clinical Research Division Institut Curie Paris France; 3. University of Versaille St Quentin/Paris Saclay Paris France; 4. STAMPM, INSERM U1331 Paris France
356
天
337
天
CUI ‐ MET : A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple‐Dose, Multiple‐Outcome Randomized Trials
作者Fanni Zhang; Kristine Broglio; Michael Sweeting; Gina D'Angelo
作者单位1. Oncology Biometrics, AstraZeneca Gaithersburg Maryland USA; 2. Oncology Biometrics, AstraZeneca London UK
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天